NIMBLE Diagnostics Selected for WomenTechEU

WomenTechEU is a grant that targets companies led by innovation and women that aim to change the world. NIMBLE Diagnostics’ CTO Susana Amorós Garcia de Valdecasas has been selected as one of few for this prestigious recognition that works to support deep-tech start-ups led by women in the field. This distinguished reward will accelerate NIMBLE Diagnostics’ ambition of bringing their breakthrough technology to cardiovascular patients as soon as possible.